| Kenneth David Lawrence, OTRL | |
|
505 S Main St, Suite 249, Las Cruces, NM 88001-1206 | |
| (505) 527-5823 | |
| (505) 527-5886 |
| Full Name | Kenneth David Lawrence |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 505 S Main St, Las Cruces, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144357039 | NPI | - | NPPES |
| J2615 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 822 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth David Lawrence, OTRL 505 S Main St, Suite 249, Las Cruces, NM 88001-1206 Ph: (505) 527-5823 | Kenneth David Lawrence, OTRL 505 S Main St, Suite 249, Las Cruces, NM 88001-1206 Ph: (505) 527-5823 |
News Archive
Scientists at Washington University School of Medicine in St. Louis have discovered a new drug target that could improve the effectiveness of radiation for hard-to-treat cancers.
Bottom Line: Baseball players are highly susceptible to shoulder injuries due to significant microtrauma including repetitive overhead throwing. Mount Sinai researchers investigated men's National Collegiate Athletic Association (NCAA) baseball shoulder injury rates and associated risk factors.
Endo Pharmaceuticals today announced actions designed to advance the company's leadership and growth in pain management, including an agreement to acquire all outstanding shares of Penwest Pharmaceuticals for $5.00 in cash per share, or an estimated enterprise value of approximately $144 million at the time of deal close. Penwest has been working with Endo since 1997 on the development and commercialization of OPANA® ER and receives a royalty stream on net sales of the product.
New research on rat heart cells suggests that a well-known antioxidant found in red wine, called resveratrol, may benefit heart tissue by limiting the effects of a condition called cardiac fibrosis.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced positive top-line results from its IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials, the phase III studies that assessed XIAFLEX (collagenase clostridium histolyticum or CCH), a novel, in-office, first-in-class biologic therapy for the potential treatment of Peyronie's disease (PD).
› Verified 7 days ago
Kandy J Bracken, O.T. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4441 E Lohman Ave, Las Cruces, NM 88011 Phone: 575-521-6470 | |
Ms. Vicki L Bennett, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1005 Lujan Hill Rd, Las Cruces, NM 88007 Phone: 575-523-4573 | |
Kristi Shoaf, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 301 Perkins Dr, Ste C, Las Cruces, NM 88005 Phone: 575-523-7243 Fax: 575-525-5641 | |
Dwell Therapy Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 424 N Main St, Ste 400, Las Cruces, NM 88001 Phone: 575-639-1175 | |
Sarah Elizabeth Schwab, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 505 S Main St, Suite 249, Las Cruces, NM 88001 Phone: 505-527-5823 Fax: 505-527-5886 | |
Joseph Kirker, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3751 Piedras Negras Dr, Las Cruces, NM 88012 Phone: 575-313-4563 | |
Samantha Kristian Perez, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 2404 S Locust St Ste 5, Las Cruces, NM 88001 Phone: 575-640-7594 |